Nami Okamoto

Japan Organization of Occupational Health and Safety — Japan

Medicine · Health Sciences

13h-index614citations43works2.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Autoimmune and Inflammatory Disorders Research(18), Adolescent and Pediatric Healthcare(11), Rheumatoid Arthritis Research and Therapies(7), Cardiac Imaging and Diagnostics(6), Kawasaki Disease and Coronary Complications(6)

Publications43 total

TeMPRA: advancing continuing professional development in pediatric rheumatology in Japan
Pediatric Rheumatology·2026Open Access
Three-year safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: Final analysis of an all-case postmarketing surveillance study
Modern Rheumatology·2025· 3 citedOpen Access
Human monoclonal anti-human IL-17A antibody (Secukinumab)
Nihon Shoni Arerugi Gakkaishi The Japanese Journal of Pediatric Allergy and Clinical Immunology·2024Open Access
Safety of baricitinib in Japanese patients with rheumatoid arthritis in clinical use: 3-year data of all-case postmarketing surveillance study
Modern Rheumatology·2024· 9 citedOpen Access
POS0768 A SYSTEMATIC REVIEW FOR THE TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS WITH OLIGOARTHRITIS OR POLYARTHRITIS INFORMING THE 2024 JAPAN COLLEGE OF RHEUMATOLOGY CLINICAL PRACTICE GUIDELINES
Annals of the Rheumatic Diseases·2024
Efficacy and safety of tumor necrosis factor inhibitors for systemic juvenile idiopathic arthritis: A systematic review
Modern Rheumatology·2024· 4 cited
Efficacy and safety of abatacept for systemic juvenile idiopathic arthritis: A systematic review
Modern Rheumatology·2024· 3 cited
Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial
The Lancet·2023· 64 citedOpen Access
POS0760 LONG-TERM PROGNOSTIC FOLLOW-UP OF PATIENTS WITH REFRACTORY SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS AFTER THE CLINICAL TRIAL OF TOCILIZUMAB AS A FIRST-LINE BIOLOGIC TREATMENT
Annals of the Rheumatic Diseases·2023· 1 citedOpen Access
Treatment for macrophage activation syndrome associated with systemic juvenile idiopathic arthritis in Japan
International Journal of Rheumatic Diseases·2023· 5 citedOpen Access
Survey of diversity awareness and environment among members of the Pediatric Rheumatology Association of Japan
Pediatrics International·2023· 1 citedOpen Access
Epidemiology conduction of paediatric rheumatic diseases based on the registry database of the Pediatric Rheumatology Association of Japan
Modern Rheumatology·2022· 11 cited
Safety and effectiveness of baricitinib for rheumatoid arthritis in Japanese clinical practice: 24-week results of all-case post-marketing surveillance
Modern Rheumatology·2022· 24 citedOpen Access
A nationwide questionnaire survey on the prevalence of ankylosing spondylitis and non-radiographic axial spondyloarthritis in Japan
Modern Rheumatology·2021· 19 citedOpen Access
AB0249 SAFETY OF BARICITINIB IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS (RA): THE 2020 INTERIM REPORT FROM ALL-CASE POST MARKETING SURVEILLANCE IN CLINICAL PRACTICE
Annals of the Rheumatic Diseases·2021· 7 cited
Utility of the EULAR Sjögren syndrome disease activity index in Japanese children: a retrospective multicenter cohort study
Pediatric Rheumatology·2020· 2 citedOpen Access
Clinical practice guidance for Sjögren’s syndrome in pediatric patients (2018) – summarized and updated
Modern Rheumatology·2020· 23 cited
Clinical characteristics and treatment of 50 cases of Blau syndrome in Japan confirmed by genetic analysis of the NOD2 mutation
Annals of the Rheumatic Diseases·2020· 76 cited
Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
Pediatric Rheumatology·2020· 46 citedOpen Access
AB1050 TOCILIZUMAB MODIFIES CLINICAL MANIFESTATIONS AND LABORATORY FEATURES OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS ASSOCIATED MACROPHAGE ACTIVATION SYNDROME
Annals of the Rheumatic Diseases·2019· 3 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Masaaki Mori(14), Hiroaki Umebayashi(13), Masato Yashiro(11), Naomi Iwata(11), Masaki Shimizu(11), Hiroshi Tamai(9), Yasuo Nakagishi(9), Kosuke Shabana(8), Takuji Murata(8), Mao Mizuta(8), Takahiro Yasumi(8), Kenichi Nishimura(8), Yuka Okura(7), Noriko Kinjo(7), Junko Yasumura(7), Tomohiro Kubota(6), Hiroyuki Wakiguchi(6), Ayako Nakajima(6), Michael W. Beresford(6), Syuji Takei(5)